- Home
- FOXX vs TPST Comparison
FOXX vs TPST Comparison
Compare FOXX & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXX
- TPST
- Stock Information
- Founded
- FOXX 2017
- TPST 2011
- Country
- FOXX United States
- TPST United States
- Employees
- FOXX N/A
- TPST N/A
- Industry
- FOXX
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- FOXX
- TPST Health Care
- Exchange
- FOXX Nasdaq
- TPST Nasdaq
- Market Cap
- FOXX 37.7M
- TPST 33.0M
- IPO Year
- FOXX N/A
- TPST N/A
- Fundamental
- Price
- FOXX $6.50
- TPST $7.76
- Analyst Decision
- FOXX
- TPST Hold
- Analyst Count
- FOXX 0
- TPST 3
- Target Price
- FOXX N/A
- TPST $30.00
- AVG Volume (30 Days)
- FOXX 8.4K
- TPST 80.4K
- Earning Date
- FOXX 08-15-2025
- TPST 08-07-2025
- Dividend Yield
- FOXX N/A
- TPST N/A
- EPS Growth
- FOXX N/A
- TPST N/A
- EPS
- FOXX N/A
- TPST N/A
- Revenue
- FOXX $53,866,257.00
- TPST N/A
- Revenue This Year
- FOXX N/A
- TPST N/A
- Revenue Next Year
- FOXX N/A
- TPST N/A
- P/E Ratio
- FOXX N/A
- TPST N/A
- Revenue Growth
- FOXX 3899.98
- TPST N/A
- 52 Week Low
- FOXX $2.45
- TPST $5.35
- 52 Week High
- FOXX $12.80
- TPST $28.34
- Technical
- Relative Strength Index (RSI)
- FOXX N/A
- TPST 63.65
- Support Level
- FOXX N/A
- TPST $6.11
- Resistance Level
- FOXX N/A
- TPST $6.49
- Average True Range (ATR)
- FOXX 0.00
- TPST 0.35
- MACD
- FOXX 0.00
- TPST 0.03
- Stochastic Oscillator
- FOXX 0.00
- TPST 100.00
About FOXX Foxx Development Holdings Inc. Common Stock
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.